tradingkey.logo

Bioharvest Sciences Inc

BHST
View Detailed Chart

8.960USD

+0.255+2.93%
Close 09/19, 16:00ETQuotes delayed by 15 min
155.31MMarket Cap
LossP/E TTM

Bioharvest Sciences Inc

8.960

+0.255+2.93%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.93%

5 Days

+1.70%

1 Month

-2.72%

6 Months

+45.69%

Year to Date

+44.98%

1 Year

0.00%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
41 / 102
Overall Ranking
186 / 4720
Industry
Food & Tobacco

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
14.750
Target Price
+69.44%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 358.13% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 25.19M.
Undervalued
The company’s latest PE is -13.08, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.61M shares, increasing 0.22% quarter-over-quarter.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Ticker SymbolBHST
CompanyBioharvest Sciences Inc
CEOMr. Ilan Sobel
Websitehttps://bioharvest.com/about/
KeyAI